DDX41
Basic information
Region (hg38): 5:177511577-177516961
Links
Phenotypes
GenCC
Source:
- DDX41-related hematologic malignancy predisposition syndrome (Strong), mode of inheritance: AD
- DDX41-related hematologic malignancy predisposition syndrome (Strong), mode of inheritance: AD
- DDX41-related hematologic malignancy predisposition syndrome (Definitive), mode of inheritance: AD
- DDX41-related hematologic malignancy predisposition syndrome (Definitive), mode of inheritance: AD
- acromesomelic dysplasia (Limited), mode of inheritance: AR
- DDX41-related hematologic malignancy predisposition syndrome (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Familial myeloproliferative/lymphoproliferative neoplasms, multiple types, susceptibility to | AD | Oncologic | Among other findings, individuals have been described with hematologic malignancies, and awareness may allow early detection and management | Allergy/Immunology/Infectious; Oncologic | 25920683; 26712909 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (788 variants)
- not_provided (551 variants)
- DDX41-related_hematologic_malignancy_predisposition_syndrome (209 variants)
- DDX41-related_disorder (69 variants)
- not_specified (56 variants)
- Acute_myeloid_leukemia (4 variants)
- Myelodysplasia (3 variants)
- Bone_marrow_hypocellularity (3 variants)
- Myelodysplastic_syndrome (1 variants)
- Hereditary_cancer-predisposing_syndrome (1 variants)
- Aplastic_anemia (1 variants)
- Inherited_acute_myeloid_leukemia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DDX41 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016222.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 15 | 293 | 308 | |||
missense | 26 | 413 | 62 | 506 | ||
nonsense | 14 | 10 | 25 | |||
start loss | 2 | 1 | 3 | |||
frameshift | 31 | 19 | 53 | |||
splice donor/acceptor (+/-2bp) | 23 | 31 | ||||
Total | 53 | 79 | 438 | 355 | 1 |
Highest pathogenic variant AF is 0.000200757
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DDX41 | protein_coding | protein_coding | ENST00000507955 | 17 | 5893 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.59e-8 | 0.998 | 125659 | 0 | 89 | 125748 | 0.000354 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.28 | 272 | 401 | 0.679 | 0.0000253 | 4056 |
Missense in Polyphen | 67 | 112.95 | 0.59317 | 1189 | ||
Synonymous | -2.77 | 199 | 155 | 1.28 | 0.0000102 | 1201 |
Loss of Function | 2.81 | 18 | 36.3 | 0.496 | 0.00000190 | 408 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000547 | 0.000547 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000544 | 0.000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000481 | 0.000466 |
Middle Eastern | 0.000544 | 0.000544 |
South Asian | 0.000327 | 0.000327 |
Other | 0.000816 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Probable ATP-dependent RNA helicase. Is required during post-transcriptional gene expression. May be involved in pre-mRNA splicing. {ECO:0000269|PubMed:25920683}.;
- Disease
- DISEASE: Myeloproliferative/lymphoproliferative neoplasms, familial (MPLPF) [MIM:616871]: A familial cancer predisposition syndrome with incomplete penetrance, characterized by increased susceptibility to myeloid neoplasms and rarely to lymphoid malignancies. MPLPF inheritance is autosomal dominant. {ECO:0000269|PubMed:25920683, ECO:0000269|PubMed:26712909}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- STING mediated induction of host immune responses;Regulation of innate immune responses to cytosolic DNA;Innate Immune System;Immune System;IRF3-mediated induction of type I IFN;Cytosolic sensors of pathogen-associated DNA
(Consensus)
Recessive Scores
- pRec
- 0.258
Intolerance Scores
- loftool
- rvis_EVS
- -1.09
- rvis_percentile_EVS
- 7.05
Haploinsufficiency Scores
- pHI
- 0.225
- hipred
- Y
- hipred_score
- 0.603
- ghis
- 0.638
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.733
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ddx41
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- ddx41
- Affected structure
- positive regulation of NIK/NF-kappaB signaling
- Phenotype tag
- abnormal
- Phenotype quality
- disrupted
Gene ontology
- Biological process
- mRNA splicing, via spliceosome;apoptotic process;cell population proliferation;cell differentiation;positive regulation of type I interferon production;cellular response to interferon-beta;positive regulation of transcription by RNA polymerase II;defense response to virus
- Cellular component
- nucleus;spliceosomal complex;endoplasmic reticulum;cytosol;membrane;catalytic step 2 spliceosome
- Molecular function
- DNA binding;RNA binding;helicase activity;protein binding;ATP binding;metal ion binding